Questions remain on progestin effectiveness for advanced and recurrent endometrial cancer

BJOG: An International Journal of Obstetrics & GynaecologyEarly View LETTER TO THE EDITOR Questions remain on progestin effectiveness for advanced and recurrent endometrial cancer Yue Qi, Yue Qi Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, Shenyang, ChinaSearch for more papers by this authorJin Zhang, Corresponding Author Jin Zhang [email protected] Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, Shenyang, China Correspondence Jin Zhang, Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, 36# Sanhao Street, Heping District, Shenyang, China. Email: [email protected]Search for more papers by this author Yue Qi, Yue Qi Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, Shenyang, ChinaSearch for more papers by this authorJin Zhang, Corresponding Author Jin Zhang [email protected] Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, Shenyang, China Correspondence Jin Zhang, Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, 36# Sanhao Street, Heping District, Shenyang, China. Email: [email protected]Search for more papers by this author First published: 27 June 2023 https://doi.org/10.1111/1471-0528.17582Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1van Weelden WJ, Birkendahl PB, Lalisang RI, IntHout J, Kruitwagen RFPM, Romano A, et al. The effect of progestin therapy in advanced and recurrent endometrial cancer: a systematic review and meta-analysis. BJOG. 2023; 130(2): 143–52. 2Anderson DG. Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetate. Am J Obstet Gynecol. 1965; 92: 87–99. 3Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol. 1996; 14(2): 357–61. 4Pandya KJ, Yeap BY, Weiner LM, Krook JE, Erban JK, Schinella RA, et al. Megestrol and tamoxifen in patients with advanced endometrial cancer: an eastern cooperative oncology group study (E4882). Am J Clin Oncol. 2001; 24(1): 43–6. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation